HARBOR CAPITAL ADVISORS, INC.

Position in ALKS — Alkermes plc.

CIK 1039128 CHICAGO, IL

Position in ALKS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$36,680

+$10,443 QoQ

Shares Held

700

-5.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#335

of 421 holders

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $8,299,759 across 12 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	39,698	$4,404,096
2	ELAN	Elanco Animal Health Inc	65,730	$1,617,615
3	COLL	Collegium Pharmaceutical, Inc	24,799	$897,723
4	PAHC	Phibro Animal Health Corp	25,398	$797,497
5	ZTS	Zoetis Inc.	5,315	$381,935
6	UTHR	UNITED THERAPEUTICS Corp	213	$115,409
7	ALKS	Alkermes plc. This page	700	$36,680
8	AMRX	Amneal Pharmaceuticals, Inc.	1,242	$21,499

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,680	700	-5.7%	Shares	Sole	2026-08-07
2026-03-31	$26,237	742	+159.4%	Shares	Sole	2026-04-28
2025-12-31	$8,002	286	+23.3%	Shares	Sole	2026-01-20
2025-09-30	$6,960	232	-9.7%	Shares	Sole	2025-10-15
2025-06-30	$7,352	257	+22.4%	Shares	Sole	2025-07-09
2025-03-31	$6,934	210	-99.6%	Shares	Sole	2025-04-14
2024-06-30	$1,152,269	47,812	+120.3%	Shares	Sole	2024-07-09
2024-03-31	$587,419	21,700	+119.1%	Shares	Sole	2024-05-13
2023-12-31	$274,709	9,903	-13.9%	Shares	Sole	2024-01-08
2023-09-30	$322,002	11,496	-35.6%	Shares	Sole	2023-10-20
2023-06-30	$558,360	17,839	-53.2%	Shares	Sole	2023-07-11
2023-03-31	$1,074,856	38,129	-5.0%	Shares	Sole	2023-04-26
2022-12-31	$1,048,440	40,124	+215.5%	Shares	Sole	2023-01-20
2022-09-30	$283,992	12,718	—	Shares	Sole	2022-10-28
No filing history on record for this holder in this stock.